To explore whether TRPM2 knockdown improved DCM under the state of hyperglycemia, we knocked down TRPM2 expression with by a single caudal vein injection of ~ 1 × 1011 genome copies of recombinant AAV9-U6-shTRPM2 at 6 weeks of age. The gene discussed is TRPM2; the disease is Hyperglycemia.